Source EurekAlert: Scientists of the Technical University of Munich (TUM) and the Max Planck Institute of Psychiatry have identified four new risk genes that are altered in German patients with multiple sclerosis (MS). The results point to a possible involvement of cellular mechanisms in the development of the disease, through which environmental influences affect gene… Read more »
Posts Categorized: MS News
New report calls for neurology care to be delivered closer to home
Source MS Trust: The Thames Valley Strategic Clinical Network launches a new report (link is external) calling for improvements in neurological services provided in the community. The report slams the current provision of care for people with long-term neurological conditions, describing it as unsatisfactory from all perspectives, including those of patients, carers and commissioners (the… Read more »
MS Society key publications (June) available through the MS Society or here at the Centre
Please note the download-only DMT factsheets will be available shortly. Key Publications (Word) June 2016 Key Publications (Word) June 2016 (1)
New treatment can ‘halt’ multiple sclerosis, says study
Aggressive chemotherapy followed by a stem cell transplant can halt the progression of multiple sclerosis (MS), a small study has suggested. The research, published in The Lancet, looked at 24 patients aged between 18 and 50 from three hospitals in Canada. Read more
Symptoms of MS halted by cell therapy by Andrew Gregory, Health Editor
Article in Daily Mirror, 10th June: A stem cell treatment can halt symptoms of ms in sufferers. Chemotherapy was used to destroy the immune system of 24 MS patients. Doctors ‘reset’ them using the cells from bone marrow. It stopped relapses and development of new brain lesions in 23 of the patients for a… Read more »
Disappointing results from opicinumab (anti-LINGO-1) study
Source MS Trust: Preliminary results announced in a company report that opicinumab (also known as anti-LINGO-1 or BIIB033) failed to improve disability, assessed by a combination of physical and cognitive measures. For more information click here.
New report shows MS forcing many newly diagnosed out of work
Source MS Society: Half the people living with MS in the UK who aren’t currently employed were forced to stop working within three years of their diagnosis according to a report released today. The MS International Federation’s Global Employment Report 2016 also claims fatigue, cognitive impairment and mobility issues are the most common symptoms forcing… Read more »
Fasting-mimicking diet studied as potential MS treatment
Source MS Trust: A diet that mimics the effects of fasting may have a role in managing multiple sclerosis according to new research. Researchers in California tested a diet that involves eating half the usual number of calories for three days in every seven. When mice with a disease similar to MS were fed the… Read more »
Rare genetic mutation associated with rapidly progressive form of MS
Source MS Society: Researchers found a particular difference in this gene (otherwise known as a gene variant or mutation) was associated with an increased risk of developing rapidly progressive forms of MS. Read on.
Relapses prevented in MS Mouse Model
Researchers at the University of Heidelberg, Germany, recently showed that peripheral blood cells loaded with a drug that resembles the myelin protein are able to inhibit harmful immune responses and prevent relapses in a mouse model of relapsing-remitting multiple sclerosis (MS). The findings were described in the study “Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells… Read more »
